Y-Intercept (HK)’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$173K Sell
32,721
-122,197
-79% -$781K ﹤0.01% 1583
2026
Q1
$1.13M Buy
154,918
+3,736
+2% +$33.8K 0.02% 980
2025
Q4
$1.45M Buy
+151,182
New +$1.56M 0.03% 790
2025
Q3
Sell
-239,608
Closed -$1.91M 1891
2025
Q2
$1.91M Buy
239,608
+201,353
+526% +$1.41M 0.05% 621
2025
Q1
$278K Sell
38,255
-26,173
-41% -$190K 0.02% 930
2024
Q4
$444K Sell
64,428
-47,551
-42% -$327K 0.03% 781
2024
Q3
$825K Buy
111,979
+98,969
+761% +$925K 0.05% 529
2024
Q2
$137K Buy
+13,010
New +$165K 0.01% 1225
2024
Q1
Sell
-12,455
Closed -$242K 1639
2023
Q4
$242K Sell
12,455
-8,260
-40% -$152K 0.02% 906
2023
Q3
$439K Buy
20,715
+1,158
+6% +$30.1K 0.04% 617
2023
Q2
$649K Buy
+19,557
New +$720K 0.07% 462
2022
Q4
Sell
-23,987
Closed -$800K 1238
2022
Q3
$800K Buy
23,987
+18,296
+321% +$762K 0.08% 360
2022
Q2
$246K Buy
+5,691
New +$261K 0.03% 637
2021
Q4
Sell
-9,387
Closed -$380K 791
2021
Q3
$380K Buy
+9,387
New +$475K 0.07% 409

Other funds holding NUS

Y-Intercept (HK)'s NUS Position: Q2 2026 in Review

Y-Intercept (HK) reduced its Nu Skin (NUS) stake by 79% in Q2 2026, selling an estimated $781K and leaving 32,721 shares worth $173K. The position accounts for ﹤0.01% of the portfolio, ranked #1583.

Y-Intercept (HK) first reported a position in NUS in Q3 2021 and has held it in 14 quarters since. The position peaked at $1.91M in Q2 2025. 23 funds tracked by Wall St. Rank hold NUS as of Q2 2026.

  • Y-Intercept (HK) held 32,721 shares of Nu Skin worth $173K as of Q2 2026.
  • Y-Intercept (HK) sold 122,197 Nu Skin shares in Q2 2026, an estimated $781K.
  • Nu Skin made up ﹤0.01% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1583 holding.
  • Y-Intercept (HK) first reported a position in Nu Skin in Q3 2021 and has held it in 14 quarters since.
  • Y-Intercept (HK)'s Nu Skin position peaked at $1.91M in Q2 2025.
  • 23 funds tracked by Wall St. Rank held Nu Skin as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.